BRPI0309421A8 - Método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia - Google Patents

Método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia

Info

Publication number
BRPI0309421A8
BRPI0309421A8 BRPI0309421A BR0309421A BRPI0309421A8 BR PI0309421 A8 BRPI0309421 A8 BR PI0309421A8 BR PI0309421 A BRPI0309421 A BR PI0309421A BR 0309421 A BR0309421 A BR 0309421A BR PI0309421 A8 BRPI0309421 A8 BR PI0309421A8
Authority
BR
Brazil
Prior art keywords
compositions
foodstuffs
risk
methods
cardiovascular disease
Prior art date
Application number
BRPI0309421A
Other languages
English (en)
Other versions
BRPI0309421B8 (pt
BR0309421A (pt
BRPI0309421B1 (pt
Inventor
A Bringe Neal
Karunanandaa Kanthasamy
Original Assignee
Monsanto Technology Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Technology Llc filed Critical Monsanto Technology Llc
Publication of BR0309421A publication Critical patent/BR0309421A/pt
Publication of BRPI0309421A8 publication Critical patent/BRPI0309421A8/pt
Publication of BRPI0309421B1 publication Critical patent/BRPI0309421B1/pt
Publication of BRPI0309421B8 publication Critical patent/BRPI0309421B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/14—Vegetable proteins
    • A23J3/16—Vegetable proteins from soybean
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/347—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of proteins from microorganisms or unicellular algae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)

Abstract

"COMPOSIÇÕES DE PROTEÍNA ASSOCIADA COM CORPO OLEOSO E MÉTODOS DE USO DESTAS PARA REDUZIR O RISCO DE DOENÇA CARDIOVASCULAR". São fornecidos composições e métodos para reduzir hipercolesterolemia e, consequentemente, o risco de doença cardiovascular. Tais composições podem compreender isolated proteínas associada com corpo oleoso. Adicionalmente provided are gêneros alimentícios to which one ou mais proteínas associada com corpo oleoso have been added. As composições employed in a invenção pode também comprise additive compostos, por exemplo, uma saponina, an isoflavona, um fosfolipídeo, a carboidrato substancialmente resistente à digestão, ou a combination thereof. Os métodos e composições da invenção may be used to lower cholesterol and other lipid levels in subjects to achieve a reduction in the risk of doença cardiovascular.
BRPI0309421A 2002-04-18 2003-04-17 método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia BRPI0309421B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37346002P 2002-04-18 2002-04-18
US60/373,460 2002-04-18
PCT/US2003/012009 WO2003088749A1 (en) 2002-04-18 2003-04-17 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease

Publications (4)

Publication Number Publication Date
BR0309421A BR0309421A (pt) 2005-02-01
BRPI0309421A8 true BRPI0309421A8 (pt) 2017-12-05
BRPI0309421B1 BRPI0309421B1 (pt) 2018-06-26
BRPI0309421B8 BRPI0309421B8 (pt) 2021-05-25

Family

ID=29251031

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0309421A BRPI0309421B8 (pt) 2002-04-18 2003-04-17 método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia

Country Status (13)

Country Link
US (1) US7541329B2 (pt)
EP (1) EP1494536B1 (pt)
JP (1) JP5219326B2 (pt)
KR (1) KR101238752B1 (pt)
CN (2) CN1662142A (pt)
AU (1) AU2003221982B2 (pt)
BR (1) BRPI0309421B8 (pt)
CA (1) CA2482464C (pt)
IL (1) IL164647A (pt)
MX (1) MXPA04010310A (pt)
NO (1) NO333937B1 (pt)
NZ (1) NZ536466A (pt)
WO (1) WO2003088749A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20020147A1 (it) * 2002-01-29 2003-07-29 Indena Spa Estrazione purificazione e modificazione di polipeptidi da seme di soia
EP1799831A4 (en) * 2004-10-06 2007-11-21 Sembiosys Genetics Inc PROCESS FOR MODULATING OLEOSINE EXPRESSION IN PLANTS
JPWO2006101181A1 (ja) * 2005-03-23 2008-09-04 不二製油株式会社 肝機能障害予防もしくは改善組成物、及び肝機能障害予防もしくは改善法
WO2007026674A1 (ja) * 2005-08-29 2007-03-08 Fuji Oil Company, Limited 大豆蛋白質組成物を配合する麺類および麺皮類
US7695744B1 (en) 2005-11-16 2010-04-13 Kareem M Zubair Natural supplement of cholesterol lowering oil seeds and nuts and method of manufacture
JP4963044B2 (ja) * 2006-07-05 2012-06-27 不二製油株式会社 ユビキチンリガーゼ阻害剤
JP3944864B1 (ja) * 2006-07-31 2007-07-18 株式会社Ｊ−オイルミルズ メタボリックシンドロームの予防および改善用組成物
US9101161B2 (en) * 2006-11-02 2015-08-11 The Coca-Cola Company High-potency sweetener composition with phytoestrogen and compositions sweetened therewith
US8124157B2 (en) * 2006-12-14 2012-02-28 Fuji Oil Company, Limited Noodles and noodle skins comprising soybean protein composition and the method of making same
WO2009089115A1 (en) * 2008-01-04 2009-07-16 Hormel Foods Corporation Encapsulation of oxidatively unstable compounds
US20110020519A1 (en) * 2008-01-04 2011-01-27 Aveka, Inc. Encapsulation of oxidatively unstable compounds
JP5752874B2 (ja) * 2008-08-08 2015-07-22 株式会社ファンケル 血流改善組成物
US20120070520A1 (en) * 2009-05-26 2012-03-22 Hyun Jung Shin Composition containing a bean extract for improving blood circulation and increasing vascular health
EP2611283B1 (en) 2010-08-30 2016-08-10 Ben-Gurion University Of The Negev Research And Development Authority Oil globule protein and uses thereof
WO2012097220A2 (en) * 2011-01-13 2012-07-19 The Trustees Of The University Of Pennsylvania Novel vesicles and nanostructures from recombinant proteins
US20140024714A1 (en) * 2011-02-07 2014-01-23 Commonwealth Scientific And Industrial Research Organisation Artificial oil bodies
WO2013052853A2 (en) * 2011-10-07 2013-04-11 Purdue Research Foundation Products containing partially hydrolyzed soy beta-conglycinin, and related methods
CN118206611A (zh) * 2022-12-15 2024-06-18 中国科学院大连化学物理研究所 一种细胞表面蛋白靶向化合物及细胞表面蛋白富集方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642490A (en) 1967-03-27 1972-02-15 Ralston Purina Co Method of treating vegetable protein
US3694221A (en) 1970-01-30 1972-09-26 Ralston Purina Co Enzyme modified protein process
US4360537A (en) 1976-05-03 1982-11-23 International Telephone And Telegraph Corporation Lipoprotein emulsions for food use and methods for preparing the same
NZ183822A (en) * 1976-05-03 1980-05-08 Itt Method for preparing a lipoprotein emulsion :an egg yolk replacer
US5725899A (en) * 1978-03-16 1998-03-10 Cole; Morton S. Protein-lipid emulsifying and gelling composition and method of preparing same
CN86105538A (zh) 1986-07-25 1988-02-24 平乡县粮食局油脂加工厂 一种食用油精炼方法
WO1989001495A1 (fr) 1987-08-07 1989-02-23 Fuji Oil Company, Limited Agent abaisseur du niveau de cholesterol
JPH0725796B2 (ja) * 1987-08-07 1995-03-22 不二製油株式会社 降コレステロール物質
CA2077020A1 (en) 1991-09-03 1993-03-04 Yoshikazu Isono Process for producing lipoprotein-containing substance having reduced lipid content and food containing substance thus produced
FR2681219B1 (fr) 1991-09-16 1993-11-26 Ard Sa Produit lipidoproteique derive de la farine de ble, son procede de preparation et ses applications.
JPH05168428A (ja) * 1991-12-21 1993-07-02 Yuichiro Onozuka 大豆からの麺状食品製造法
EP0656786B2 (en) * 1992-05-19 2014-04-23 Novogen Research Pty Ltd Use of isoflavone phyto-oestrogen extracts of soy or clover
US5559220A (en) * 1993-09-14 1996-09-24 Midwest Research Institute Gene encoding acetyl-coenzyme A carboxylase
EP0790060B1 (en) * 1995-09-06 2003-11-12 Kyowa Hakko Kogyo Co., Ltd. Substance ameliorant le metabolisme des graisses
US5968516A (en) * 1995-10-03 1999-10-19 Liu; Yaguang Soybean drug and new method of extracting soybean saponins
PL184852B1 (pl) 1996-02-29 2002-12-31 Nutri Pharma As Kompozycja na bazie składników soi
US6171640B1 (en) * 1997-04-04 2001-01-09 Monsanto Company High beta-conglycinin products and their use
US5855892A (en) 1997-09-19 1999-01-05 Potter; Susan M. Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
IL137153A (en) * 1998-01-07 2003-07-31 Diamond George B Crisp fried in grapeseed oil
AU3085299A (en) * 1998-03-12 1999-09-27 Board Of Trustees Of The University Of Arkansas, The Tertiary structure of peanut allergen ara h 1
JP3030339B2 (ja) * 1998-08-07 2000-04-10 農林水産省農業生物資源研究所長 ダイズグリシニンを発現するトランスジェニック植物
MXPA01005276A (es) 1998-11-25 2002-04-24 Sembiosys Genetics Inc Cuerpos grasos como vehiculos de suministro topico para agentes activos.
WO2000030663A1 (en) 1998-11-25 2000-06-02 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases
US6544566B1 (en) * 1999-04-23 2003-04-08 Protein Technologies International, Inc. Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
US6413569B1 (en) * 1999-09-29 2002-07-02 Archer-Daniels-Midland Company Use of isolated soy protein for making fresh, unripened cheese analogs
JP3441411B2 (ja) 1999-10-12 2003-09-02 明治乳業株式会社 コレステロール低減化ペプチド
ATE270340T1 (de) 1999-11-18 2004-07-15 Nestle Sa Rekombinante oleosine aus kakao und deren verwendung als geschmacksstoffe oder emulgatoren
US6864362B2 (en) * 2000-03-16 2005-03-08 E. I. Du Pont De Nemours And Company Hypoallergenic transgenic soybeans
JP3619137B2 (ja) 2000-09-28 2005-02-09 日本水産株式会社 オイルボディ様またはシェル状ナノカプセルおよびその製造方法
AU2001290293A1 (en) * 2000-09-28 2002-04-08 Ajinomoto Co. Inc. Oleosin/phospholipid complex and process for producing the same
AU2001290324A1 (en) * 2000-09-29 2002-04-08 Fuji Oil Company Limited Composition for diminishing neutral fat in blood
CN1237890C (zh) * 2000-10-02 2006-01-25 不二制油株式会社 分级大豆蛋白及其生产方法

Also Published As

Publication number Publication date
KR101238752B1 (ko) 2013-03-06
KR20050060031A (ko) 2005-06-21
NO20044575L (no) 2005-01-17
IL164647A0 (en) 2005-12-18
NO333937B1 (no) 2013-10-28
JP5219326B2 (ja) 2013-06-26
EP1494536A1 (en) 2005-01-12
US20050214346A1 (en) 2005-09-29
CN102240040B (zh) 2014-12-24
MXPA04010310A (es) 2005-02-17
BRPI0309421B8 (pt) 2021-05-25
BR0309421A (pt) 2005-02-01
EP1494536A4 (en) 2009-10-28
HK1162127A1 (en) 2012-08-24
BRPI0309421B1 (pt) 2018-06-26
AU2003221982A1 (en) 2003-11-03
NZ536466A (en) 2008-04-30
IL164647A (en) 2009-07-20
JP2005523007A (ja) 2005-08-04
WO2003088749A1 (en) 2003-10-30
CA2482464C (en) 2013-06-25
CA2482464A1 (en) 2003-10-30
CN102240040A (zh) 2011-11-16
AU2003221982B2 (en) 2009-04-23
EP1494536B1 (en) 2013-06-19
US7541329B2 (en) 2009-06-02
CN1662142A (zh) 2005-08-31

Similar Documents

Publication Publication Date Title
BRPI0309421A8 (pt) Método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia
BR9907189A (pt) Produtos da fração lipìdica do carotenóide de pepino do mar e métodos de uso
CO5550402A2 (es) Composicion para disminuir el colesterol en la sangre
BRPI0113042B8 (pt) composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato
BR0009651A (pt) Composto, processo para a preparação de um composto, composição farmacêutica, uso de um composto, e, método para tratar artrite reumatóide e uma doença obstrutiva das vias aéreas
BR0306846A (pt) Produto substituto do sangue, composição útil como um substituto do sangue, método para fazer um produto substituto do sangue, e, método de uso de um produto substituto do sangue para fornecer oxigênio a um tecido
BR0007823A (pt) Métodos de supressão do glucagon
BR0310099A (pt) método para tratar dislipidemia ou uma doença associada com a dislipidemia
BR0211888A (pt) Materiais e métodos para promoção de reparo de tecido nervoso
ATE533534T1 (de) Proteinhydrolysat und pflanzliche sterole enthaltende zusammensetzung für verbessern serum- lipid-profils und das verhindern von atherosclerosis
ECSP045154A (es) Composiciones de fórmula para infantes que comrende cantidades aumentadas de alfa - lactalbumin
BR9911786A (pt) Inibidores heterocìclicos de p38
CA2274596A1 (en) Compositions and methods for enhancing intestinal function
DE60104206D1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
BR9712731A (pt) Fitase a partir de feijões de soja germinados
BR9808971A (pt) Composição de gordura despejável e processo para preparar a mesma
BRPI0413553A (pt) moléculas de lubricina recombinante e usos das mesmas
EA200000181A1 (ru) Фармацевтические композиции, содержащие витамин d и кальций, их приготовление и терапевтическое применение
WO2000039280A3 (en) Leukocyte-derived interferon preparations
WO2007002836A3 (en) Methods and compositions for the prevention and treatment of kidney disease
CA2343116A1 (en) Methods and compositions for increasing intestinal absorption of fats
TR200100897T2 (tr) Lipid metabolizma bozukluklarının tedavisinde safra asitleriyle bağlı propanolamin türevleri.
DE602004005821D1 (de) Enteralpräparat zur vorbeugung gegen bzw. behandlung von sepsis
BR0009954A (pt) Produto alimentìcio espalhável, e, processo para a preparação do mesmo
WO2001005356A3 (en) Weight control product comprising a synergistic mixture of guggul extract, phosphate salt and metabolic stimulant

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT. CL. : A01N 65/00.

Ipc: A23J 3/16 (2006.01), A23L 1/305 (2006.01)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23J 3/16 (1990.01), A23J 3/34 (1990.01), A23L 33/

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/04/2003 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 17/04/2023